SAB Biotherapeutics (SABS) Operating Margin (2021 - 2024)
SAB Biotherapeutics' Operating Margin was -8726.26% in Q4 2024, down 2538.36 percentage points from -6187.90% a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Operating Margin (2021 - 2024) Analysis & Trends
For FY2024, Operating Margin at SAB Biotherapeutics came in at -3244.87%, down 1544.32 percentage points from FY2023.
- Operating Margin has now declined for four consecutive years, with a four-year change of -3282.09 percentage points (FY2020 to FY2024).
- In earlier years, Operating Margin was -1700.56% in FY2023 (-1579.58 pp), -120.97% in FY2022 (-98.97 pp), -22.00% in FY2021 (-59.22 pp) and 37.22% in FY2020.
- The Q4 2024 figure marks the lowest quarterly Operating Margin in data going back to Q1 2021.
- Compared with a year earlier, Operating Margin was higher in two of the last seven quarters, with an average year-over-year change of -1926.86 percentage points.
- The best year-over-year quarter for Operating Margin over five years was Q2 2024 (a gain of 3696.44 percentage points); the worst was Q2 2023 (a drop of 7470.37 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | SAB Biotherapeutics | 268.85 Mn | 268.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -8,726.26% |
| Jun 30, 2024 | -3,876.95% |
| Mar 31, 2024 | -1,205.90% |
| Dec 31, 2023 | -6,187.90% |
| Sep 30, 2023 | -420.00% |
| Jun 30, 2023 | -7,573.40% |
| Mar 31, 2023 | -1,273.79% |
| Dec 31, 2022 | -363.74% |
| Sep 30, 2022 | -217.49% |
| Jun 30, 2022 | -103.03% |
| Mar 31, 2022 | -56.83% |
| Dec 31, 2021 | -66.41% |
| Sep 30, 2021 | -27.18% |
| Jun 30, 2021 | -15.77% |
| Mar 31, 2021 | 4.81% |
API Access
SAB Biotherapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();